ATOP 7 Mousse and PYOclean Mousse are presented as a ‘dry shampoo’ in foam form for cats and dogs. They join the company's Dermoscent portfolio of companion animal products, developed to help with the management of scaling disorders, atopic or allergic skin disease and infections.
Both products contain a blend of plant extracts and essential oils from Hemp seed, which LDCA says has a moisturising and restructuring action on the skin. Atop 7 contains lemon tea tree extract, which the company says boosts anti-inflammatory and anti-pruritic activity. PYOclean contains lavender and manuka, which are claimed to have an anti-bacterial action.
LDCA says it has designed the two non-rinse mousses with owner compliance in mind; that used twice-weekly twice-weekly alone or in combination with other supplements or treatments as part of a skincare protocol, they can extend the time between shampoos. They can also be applied quickly to speed patients’ discharge from hospital or used when animals are boisterous or dislike baths.
According to the company, a 2-week veterinary-supervised study looking at the effect of ATOP 7 Mousse on the skin of flea-allergic and atopic dogs, reported a veterinarian general satisfaction score of 8.7/10. Owners of the dogs on the trial reported an 8.7/10 general satisfaction score and a similar score for the product’s ability to soothe irritated skin.¹
The full Dermoscent range, including the new mousses, is available through Vet Direct as well as Henry Schein (selected products) or as a special order through Centaur. ATOP 7 Mousse and PYOclean Mousse are both available in 150ml packs and are priced at £7.94 + VAT each (list price).
For more information visit: http://www.dermoscent.com. A clinical case study by Dr Jean-Loup Mathet on the use of PYOclean Shampoo, Spray and Mousse in a 14-year old West Highland White Terrier with chronic, recurrent, inflammatory, pruritic and seborrhoeic dermatosis is also available online or by request.
Reference
The survey of 97 cat owners and 156 vets conducted in June last year found that currently only 30% of cat owners give supplements to their cat but 74% would be willing to try them.
The survey also found that whilst 80% of vets thought the main reasons to be hesitant about recommending feline supplements were palatability and the owner’s ability to give products, owners were less concerned about the ease of giving the supplement (53%), and more concerned about the cost (45%) and being unsure of the benefits (39%).
Tara Evans RVN, head of sales at Vita, said: “It is interesting that the majority of vets believe that practicalities around administering oral supplements is the main drawback to giving these products, whereas only 53% of owners were concerned about this.
"Understanding owner concerns regarding efficacy and price could help vets support more owners to move forward with supplements for their cats.”
According to the survey, the most frequently used supplements, by both vets and owners are those made to support joints.
Cat owners also showed an interest in giving supplements for general wellness (61%).
Tara added: “Owners are open to supplementing for general health, as well as more specific health-related issues.”
www.vitaanimalhealth.com
The new tool is part of a package that also includes posters and SMS texts to support veterinary practices in raising awareness of gastric ulcers to horse owners.
Equine Gastric Ulcer Syndrome (EGUS) is a serious and common condition and any type of horse can be at risk.1 EGUS can have a profound impact on a horse’s condition and performance and can be life threatening in foals. It is a challenging condition to diagnose as the clinical signs are often vague and not always present.1
Gastroscopy is the only method currently available for a definitive diagnosis. Of the two types of disease equine squamous gastric disease is graded on a numeric scale with 1 being the least severe and 4 being the most serious. Equine glandular gastric disease can be very varied in terms of location and type so grading this disease on a score system is no longer recommended. Instead it is now usually described in terms of location, severity and appearance.2
The new tool has been designed to help vets to map the area affected by gastric disease and record the details in an accessible format. This information, together with treatment and management recommendations, can be shared easily with the client. Posters explaining gastric ulceration have been designed to help increase awareness and understanding of EGUS amongst horse owners.
Zoetis says effective treatment usually involves a combination of management and medical treatments. UlcerGold is indicated to treat and prevent the recurrence of gastric ulcers in horses, administered once-daily for 28 consecutive days at the full dose of 4mg/kg bodyweight followed by the reduced dose of 1mg/kg bodyweight for a further 28 days.3 It contains omeprazole, a proton pump inhibitor that suppresses gastric acid secretion.3,4 One syringe contains enough UlcerGold for a daily dose for a horse weighing up to 700kg. It can be used for foals as young as four weeks of age that weigh over 70kg and for breeding stallions.
References
Special interest groups on VetSurgeon are areas where discipline-specific news, forum discussions, CPD events and clinical images are curated in one place. They also help members with shared interests connect with each other and interact with experts in the field.
In the Small Animal Medicine Group, I am delighted to welcome two contributing experts. Firstly, Andy Kent from Willows Referral Centre, who is already well-known on VetSurgeon for his helpful, knowledgeable and thoughtful contributions. Secondly, the pharmacist Andrea Tarr who, as the founder of Veterinary Prescriber, is something of a font of knowledge.
All VetSurgeon members with an interest in small animal medicine are warmly invited to come and join the new group. You need to login, navigate to the section here, and press the 'join' button on the left hand side (you may need to rotate your mobile phone to see it). You can also subscribe to a monthly or weekly digest of content added to the section.
Whilst you're there, I'm going to offer a bottle of good wine (ie not any old plonk) to the member who starts the most interesting discussion in the forum over the next couple of weeks. It could be a general topic, or, better yet, an interesting case discussion. If the latter, it doesn't matter how old it is. If you have an interesting case in your personal archives, dig it out and share it!
Don't forget ... sharing content and contributing to the discussion it starts (or indeed just reading content in the group) can count towards your annual CPD requirement. Just click the 'Claim CPD' button at the top of the page and the system will keep a record of the page you were on, the time you spent and how you found it useful.
The Small Animal Medicine Group is the second special interest group launched so far, after the Small Animal Dentistry Group. Watch this space, there are more on the way ...
Virbac has announced the reintroduction of chews as part of its dental range.
VeggieDent chews are available in packs of 15 in sizes suitable for small, medium and large dogs. The chews contain chlorhexidine and have a texture and shape designed to optimise plaque removal by physically abrading the tooth surface during chewing.
Product manager Chris Geddes said: "The gold standard of dental hygiene is regular brushing, but that isn't always possible, and products such as this are ideal for those difficult cases."
For further information please speak to your Virbac representative, phone 01359 243243 or email admin@virbac.co.uk.
Pfizer VPS has launched a 'Pre-Sale Scab Treatment Certificate' so that sheep treated for sheep scab and protected against re-infestation beyond their autumn sale date can be formally certified as such.
A choice of two moxidectin-based treatments are eligible for use, one with 28 days and the other 60 days licensed persistency against the scab mite.
Pfizer VPS vet David Bartram explained that following treatment, the sale date must fall within the persistency window: "The idea is that farmers present their certificate at markets on sale day, then auctioneers announce the scab-protected status during their sales patter. Whether this adds to the sale price will be interesting to find out, but it's sure to be seen as a valuable attribute by buyers who won't need to treat for scab when they arrive home."
Details of the certification process are available from SQPs at animal medicine suppliers. The two eligible treatments are CYDECTIN 1% LA and CYDECTIN 2% LA for sheep.
The BSAVA reports the highest ever attendance at Congress this year: 6,178 veterinary surgeons, nurses, practice managers and students, 6% cent higher than in 2011 (the last time the BSAVA hosted its own Congress).
According to the association, a significant number of international delegates attended this year with almost 60 countries represented - notably Scandinavia (186 delegates), Germany (56), the Netherlands (40) and the USA (31).
Other highlights included:
Outgoing BSAVA president Mark Johnston said the event was the highlight of his presidential year: "Last year we showed the world how well the BSAVA can organise a major veterinary congress. But what is pleasing is that the momentum we gained from hosting the World and European meetings has continued into this year.
"We had more delegates in 2013 than in the last purely BSAVA Congress two years ago and to accomplish that in these difficult financial times is a remarkable achievement."
Newly inducted BSAVA president Michael Day (top right) said he was looking forward to extending the international aspect of BSAVA. The Australian-born Professor who has lived in the UK for well over two decades said: "BSAVA has made huge contributions to veterinary practice in the UK, and already has a global reputation for Congress and publications - I believe we have such a wealth of resources and so I am convinced we have so much more to offer the world".
MSD Animal Health UK has announced the launch of Bravecto, which it says is the first and only treatment available for fleas and ticks in dogs that is rapidly effective and offers 12-weeks duration of efficacy.
Bravecto (fluralaner) is the first of a new generation of systemically active ectoparasiticides, the isoxazolines, and will only be available on prescription through veterinary practices. The new product will be available in five strengths of pork liver flavoured palatable chew for different size dogs - one chew per weight band - which MSD says are readily accepted from the hand. Jolian Howell, marketing and technical lead at MSD Animal Health UK said: "Bravecto is a truly unique and exciting innovation which will transform the effective treatment of fleas and ticks - providing protection like never before from a single dose. It is the first in a new generation of products that offer a full 12-week protection and will help keep the treatment of fleas and ticks within veterinary practices."
He continued: "Estimates suggest that flea and tick treatments are applied for just 2.8 months per year so just one dose of Bravecto will immediately deliver much improved levels of treatment for dogs in veterinary care, which is good for the animal and good for the vet." MSD Animal Health says it is investing in the launch of Bravecto with a major marketing and practice support package which aims to raise awareness of fleas and ticks and drive pet owner footfall into practices for flea and tick control.
The new product will be available after BSAVA Congress, where MSD will be giving visitors the opportunity to learn more about it.
Royal Canin is offering Dyson Animal handheld bagless vacuum cleaners (normally retailing at £130) with orders of over £500 at Congress this year.
The Royal Canin Veterinary range will be on display, including the latest additions for cats, Renal Special Dry and Renal with Tuna.
Delegates can also find out more about Royal Canin’s programme of on-site in-practice staff training on nutrition, Pet Health Counsellor courses and extensive support material for veterinary nurses, receptionist courses, display material for the waiting room, and a helpline to ensure that vets and their teams have quick access to the most up to date information.
Everyone who drops in on Royal Canin will also be able to enter a free draw to win a flight in a hot air balloon.
Following a survey which indicates that veterinary surgeons are largely using unproven supplements to manage early-stage osteoarthritis, Hill's Pet Nutrition is calling upon vets to use evidence-based clinical nutrition to manage the condition.
The survey, which was carried out by independent market research firm Zyman Group, found that vets are more likely to give supplements than any other treatment in early stage osteoarthritis: 66% of cases receive supplements, 45% are given NSAIDs, and only 20% receive dietetic pet food.2
According to Hill's, its Prescription Diet j/d dry is clinically proven to improve mobility in osteoarthritic dogs in as little as 21 days; and 28 days in cats.3,4 Furthermore, the clinical study assigned to j/d is classified as Grade 1 level evidence - the highest grade reflecting the validity of clinical evidence. Another study has shown that Prescription Diet j/d also helps reduce NSAID dosage by up to 25 percent in dogs.5 This quality of evidence is, says Hill's, in contrast to many supplements.
John Innes, Professor of Small Animal Surgery at Liverpool, was involved in some of the early work on j/d: "Our results showed that the EPA in Hill's Prescription Diet j/d Canine pet food helped to reduce proteoglycan loss from cartilage. This would have beneficial effects in helping to preserve loss of cartilage. By preserving the cartilage, we can reduce pain in the long-term and ensure greater mobility for dogs with osteoarthritis."
Hill's has also announced that because a substantial majority of vets and nurses said that they felt that natural GACs have a positive effect in osteoarthritis1, its Prescription Diet j/d dry has been enriched with glucosamine and chondroitin sulphate.
Hill's j/d programme is now backed with money off vouchers, to improve client acceptance of veterinary recommendation. Clients who register on the website http://www.hillspetmobility.co.uk/,or http://www.hillspetmobility.ie/, will receive two £10 (or €10) money off e-coupons to use in clinic on their next purchases of j/d. They will also receive monthly e-mails containing information on how to take care of their pet with mobility problems, and help drive them back into the clinic for check-ups.
Veterinary surgeons who would like more information on the studies proving clinical efficacy, or score cards and trial guides for clients, should contact their Hill's Territory manager or call 0800 242438 or in ROI 1 800 626002. Clients can also fill in the scorecard online at www.hillspetmobility.co.uk or http://www.hillspetmobility.ie/
Kruuse UK has announced that it will be launching its new Android telemetric ECG system at BEVA 2011.
The original Televet 100 supports transmission of ECG data to a range of approx 100m (330ft), allowing recording and displaying of real time data only within a confined lunging or riding arena. By linking this system to a mobile network via 3G Android phone and a Windows 7 based tablet PC, the new Televet system overcomes this range limitation.
The new system requires the rider/horse to carry a 3G mobile phone which transmits data over the mobile internet, allowing the veterinary surgeon to display and record real time data on any PC/laptop with internet access or mobile internet connection. This also includes GPS information collected by the phone allowing the ECG, heart rate and velocity of the horse to be displayed in parallel.
The Android Telemetric ECG system is specifically targeted towards veterinary applications in the field of sports horses where extended range is particularly useful, such as endurance riding, three day eventing and racing.
Televet software can now also be integrated in Dicom infrastructures in practice for data capture and recording.
Sarah Stokes, Kruuse Equine Territory Manager said: "the flexibility and simplicity of the system along with immediate access to ECG data of patients will be an invaluable diagnostic tool for UK vets allowing vital support for patients and owners wherever they are."
Visitors to the Kruuse stand at BEVA 2011 will also have the chance to win an Acer ICONI W500 tablet worth £500.
The RCVS is advising all practices that it is not currently carrying out a data-gathering exercise and that phone calls prompting the return of a survey, and requesting mobile phone numbers, are not being made on behalf of the College.
The warning comes after several practices have called the College to query 'feedback forms' - supposedly issued in relation to the Practice Standards Scheme or the payment of members' retention fees.
The practices were asked to return forms which they had not received, and also to provide mobile phone numbers, by someone who claimed to work for the 'statutory regulator' or 'the RCVS'. Contact phone numbers left by the caller were either RCVS fax numbers or numbers which looked like RCVS direct dial numbers, but were not.
Lizzie Lockett, Head of Communications, said: "This looks like an exercise to gain mobile phone numbers which is being carried out in the College's name. We are currently investigating who might be making these calls. In the meantime, if a practice receives such a call, it would be helpful if they could take down a name and contact number and let us know."
Ring 020 7202 0725 or email l.lockett@rcvs.org.uk to report any suspicious activity.
The RCVS has announced the candidates standing in the RCVS Council and Veterinary Nurses Council elections this year and is inviting veterinary surgeons and nurses to put their questions to them directly for a video reply.
There are eleven candidates standing for election to RCVS Council in 2015. Overall there are six men and five women, which include two existing Council members eligible for re-election and nine new candidates. They are:
Three veterinary nurses are standing in this year's VN Council elections, including one existing VN Council member eligible for re-election. They are:
Ballot papers and candidates' details are due to be posted to all veterinary surgeons and veterinary nurses eligible to vote during the week commencing 16th March, and all votes must be cast, either online or by post, by 5pm on Friday, 24 April 2015.
Once again the College is inviting members of both professions to 'Quiz the candidates' by putting their questions directly to all those standing for election. Each candidate will then be invited to choose two questions to answer from all those received, and produce a video or audio recording of their answers. All recordings will be published on the RCVS website on Thursday 19 March.
Vets and nurses should email their question (NB one per person) to vetvote15@rcvs.org.uk or VNvote15@rcvs.org.uk, or post it on twitter using the hashtags #vetvote15 or #VNvote15, respectively, by midday on Monday 9 March.
Gordon Hockey, RCVS Registrar said: "It's important that members of the veterinary professions choose who they want to sit on their governing Councils, so we always try to make the elections as interesting and engaging as possible.
"This year, we hope the provision of short videos, to accompany the usual written information, will encourage people to find out a little more about all those standing for election, and then use their vote."
The report is the culmination of the work of a joint RCVS and VSC BAME Student Support Working Group, set up to explore key issues in supporting BAME veterinary students during their studies.
The Working Group made a total of 14 recommendations, which included:
Stephanie-Rae Flicker is a recent Royal Veterinary College (RVC) graduate who co-chaired the Working Group alongside Professor Rob Pettitt from the University of Liverpool.
She said: “I hope this encourages and supports our veterinary institutions to actively implement change regarding discrimination faced during studies and placements, nurturing role models and helping affected students develop sense of belonging and community during their studies and beyond.
"Many thanks to all that have contributed to the completion of this Report – we hope the recommendations have a lasting impact, and benefit those both already present and yet to enter our profession."
RCVS/VSC BAME Student Support Working Group Report.
Avid, the maker of pet microchip indentification products has developed its registration system so that Avid MicroChips can now be registered via practice management software using the VetXML schema.
This instantly registers the microchip directly on to the UK PETtrac Database, managed by Avid. All the implanter needs to do is add the microchip number to the client record, then click to register.
The practice has the option to print a receipt for the client before they leave the surgery, and a certificate confirming the registration will be posted to the client by PETtrac, usually the same day.
The microchip registration is completed in real time on the UK PETtrac Database, and is automatically checked to ensure the microchip being registered was sold to the practice completing the registration. In the event of any errors, the practice will be contacted by PETtrac to obtain the correct information.
Simon Clark, IT developer for Avid said "Avid already has direct registration via a number of practice management software packages and we are working with others to get this feature implemented as soon as possible. Registrations are now easier and quicker than ever before, and really can be completed with just one click!"
For full details about how the Avid microchip system can benefit your practice please contact the Avid sales office on 0800 652 7 977 or visit www.avidplc.com
A research project funded by The Horse Trust has discovered that a racehorse's performance does not markedly change after it has recovered from a tendon injury.
The research was led by Bryan O'Meara, who is in the final year of a three year clinical training scholarship funded by The Horse Trust.
Mr. O'Meara carried out the research at Donnington Grove Veterinary Surgery in Newbury, under the supervision of epidemiologist Dr Tim Parkin from University of Glasgow.
Tendonitis is one of the most common musculoskeletal injuries in racehorses, with a prevalence of 11-30%, according to earlier research.
Mr. O'Meara examined the clinical records and racing histories of 400 racehorses who had been treated for superficial digital flexor (SDF) tendonitis injuries over a five year period (2003-2008).
The race records of horses affected by tendon injury were compared with 400 matched control horses that had never suffered SDF tendon injuries.
The controls were horses training in the same establishment at the time of injury and of the same age and sex as the case horse.
The research looked at the performance of the racehorses in races before and after treatment for the injury, and at the performance of the control horses before and after the treatment date. The Racing Post Rating (RPR), which is published by the Racing Post after every race, was used as a measure of performance.
Mr. O'Meara found that there was no significant difference in RPR before and after the treatment date in case and control horses.
According to The Horse Trust, this result is unexpected as in vitro studies have found that healed tendon tissue has reduced elasticity due to the presence of scar tissue. This suggests that a horse with a healed SDF tendon would need to work its muscles harder to compensate and would therefore be expected to have lower performance.
Mr. O'Meara said more research is needed to back-up his finding that performance isn't significantly affected by tendon injury: "It could be that using Racing Post Rating to measure performance isn't sensitive enough to pick up a change in the horse's performance. However, it's encouraging that there's no marked change in performance after a horse has recovered from a tendon injury. These findings show that there's no need to give up on a horse that has a tendon injury - they can still come back and perform well, or can be used for other, less demanding riding activities."
The research also found that there was no significant difference between case and control horses when returning to racing and completing three races. Only after completing five races, or three years post treatment, was a significant difference found between case and control horses. This finding is a step towards developing a more accurate assessment of tendon treatment. Outcome after five races or three years post treatment is a better indicator of the outcome of treatment.
Mr. O'Meara said: "At the moment, some tendon treatments state their success as the percentage of horses that return to racing after treatment. However, we've shown that there's no significant difference between case and control horses at this time. At the moment, there are a myriad of treatments available to treat tendonitis. Hopefully this finding will be used in further research to learn which treatments are most effective."
Mr O'Meara's research also found a link between SDF tendon injury and the racehorse competing at its maximum performance level: the case horses were significantly nearer to their pre-injury maximum performance level in the race immediately before injury (compared to matched controls), suggesting that they were competing nearer their individual maximum performance level when the SDF tendon injury occured.
The Codes were approved by RCVS Council and the Veterinary Nurses Council earlier this year, following a lengthy consultation and review process that began in 2009, and will replace the existing Guides to Professional Conduct.
The College says the new Codes are principles-based, easily accessible and, at 16 pages long compared to the 50-page Guides, much more concise. They bring the College's guidance into line with the codes of conduct of other regulatory bodies, and help to describe those professional responsibilities that are fundamental to veterinary surgeons' and veterinary nurses' practice.
To expand on and clarify these professional responsibilities, an additional 27 chapters of supporting guidance have been published on the RCVS website, which also consolidate and update all existing RCVS guidance for veterinary professionals.
Both Codes set out five principles of practice: professional competence; honesty and integrity; independence and impartiality; client confidentiality and trust; and, professional accountability.
The veterinary surgeons' Code features an update to the declaration made on admission to the profession and, for the first time, the veterinary nurses' Code includes a declaration to be made on professional registration.
Among the professional responsibilities introduced in the Codes are: mandatory recording of continuing professional development; a mandatory professional development phase for new veterinary surgeons and period of supervised practice for registered veterinary nurses (RVNs) returning to practice after a break; a Performance Protocol; and, notification to the RCVS of any matter that may affect fitness to practise, including convictions (although this will require further consideration by the College).
For the first time, mandatory clinical governance has been introduced, and minimum practice standards have also been incorporated, at equivalence to the core standards set out in the RCVS Practice Standards Scheme.
A pocket-sized hard copy of the Code will be posted to all vets and RVNs shortly, which will include references to where the supporting guidance and further information can be found on the RCVS website. The online versions - at www.rcvs.org.uk/vetcode and www.rcvs.org.uk/vncode - are fully searchable by keyword, and PDF versions will soon be available to download. A digital version is also being explored, to enable veterinary surgeons and veterinary nurses to access the Codes and supporting guidance on smart phones and tablets.
Although only registered veterinary nurses have agreed to abide by the VN Code of Professional Conduct, the College hopes that all veterinary nurses will consider it a useful benchmark of professional standards.
Dr Jerry Davies, RCVS President, said: "I am delighted that this significant piece of work has come to fruition. The RCVS has shown that, despite aged legislation, the Codes will, through imaginative interpretation of the Veterinary Surgeons Act, ensure the public and their animals continue to receive the level of professional service they have come to expect from veterinary surgeons and veterinary nurses in the UK."
The 1st Reproduction Control Guidelines of the World Small Animal Veterinary Association (WSAVA) have just been accepted for publication and are expected to recommend a move away from a blanket neutering policy.
Dr Neil Mottram BSc (Hons) BVSc MRCVS Technical Manager at Virbac said: "This webinar will help clinicians understand and navigate the latest evidence-based medicine in regards to neutering.
"The panel of world-leading experts on reproduction will present their guidance on medical and surgical neutering and offer delegates the opportunity to interact with a live Q&A section at the end of the event.
https://app.livestorm.co/virbac-france/1st-reproduction-control-guidelines?type=detailed
Petplan has launched a new system through which veterinary staff at Appointed Representative (AR) practices can activate 4 weeks Immediate Veterinary Cover (IVC) for clients' puppies, kittens and rabbits at www.petplanvet.co.uk.
Petplan says the new system will greatly improve its service to the veterinary industry, enabling same day information transfer, reducing the amount of paperwork and admin for veterinary staff as well as ruling out the chances of paperwork getting lost or delayed in the post.
Simon Masding, Petplan Head of Sales and Partnerships said: "Petplan has the most established cover note scheme in the market and due to the strength of our brand and the products we offer is able to generate more insured clients for practices than any other provider. Our team of Account Executives visit practices across the UK on a daily basis which means we understand the pressures of day-to-day practice life. Our new online IVC service is just one of the innovative ways we try to make things easier for veterinary staff so they can focus on looking after clients and their pets."
For more information about becoming a Petplan AR practice, and Immediate Veterinary Cover, call Petplan's Vetline on 0800 316 8800.
Any practices that activate IVC online at petplanvet.co.uk before 31st July 2012 will be entered into a prize draw to win an iPad.
Ceva Animal Health UK, makers of Feliway for cats and Adaptil for dogs, has launched an online petition calling for the Government to force all fireworks manufacturers to carry information about pet and wildlife safety both online and on packaging and is calling for the veterinary industry to back the campaign.
Ceva says the campaign is designed to highlight the stress that Bonfire Night can cause to pets: according to the company's research more than 80 per cent of owners say their pet is afraid of the noises associated with firework season.
The petition states: Over 80 per cent of pet owners have a pet that is afraid of fireworks. Fireworks manufacturers need to accept their responsibilities and publicise pet safety information on packaging and on their websites. Adaptil call (sic) on the Government to make this a mandatory requirement.
However, that rather beggars the question: "What pet safety information?" After all, there isn't that much pet and wildlife information you can fit on packet of bangers (especially after you've added the elf 'n safety information for half-wits, like: "This product may go bang"). So perhaps the amount of pet and wildlife safety information that could be included on a firework would be limited to something like: 'Remember to check there aren't any pets about before using this firework'. But that's something most concerned pet owners do anyway, and adding the instruction to the side of a firework surely isn't going to make a blind bit of difference.
Nevertheless, Sarah Endersby at Ceva Animal Health UK, said: "This will be the second year running we have called upon the fireworks industry to recognise its responsibilities when it comes to protecting pets and wildlife during what is the most stressful season for them. For example, many dogs find fireworks distressing and may go on to develop noise phobia.
"Many owners will seek advice from pet specialists such as vets, vet nurses, pharmacists and pet shop staff. However, by producing warnings on the packaging, fireworks manufacturers can also help advise and guide pet owners to minimise the stress caused to pets."
Ceva has also produced a range of materials for fireworks to help educate owners on firework fear and how to calm and soothe their pets. There's a marketing pack which can be placed in veterinary practices which includes leaflets, a leaflet dispenser, stickers, bunting and notice-board materials.
To request a pack, please email retailuk@ceva.com or call Ceva on 01494 781 510
You'd better hope though that Ceva isn't too successful with its campaign to highlight the stress caused to pets by fireworks. If people really do become more careful about how they use fireworks, nobody will need to buy Adaptil or Feliway!
The BVA has released more results from the Voice of the Profession survey, which show that 67% of vets have seen dogs that needed conformation altering surgeries and caesareans in the last year.
Every year the Kennel Club receives over 3,200 data submissions from both vets and dog owners about conformation altering surgeries and caesareans carried out on Kennel Club registered dogs. Sharing data about conformation altering surgeries and caesareans is vital to help build a picture of the current situation, and facilitate measures to improve health and welfare for future generations of dogs.
The information collected by the Kennel Club provides details of breeding lines appearing to perpetuate certain defects. For example, data submitted for caesareans prevents the registration of puppies born to a bitch that has already had two litters delivered by caesarean section while data submitted for conformation altering surgeries allows the Kennel Club to make decisions on whether or not to allow affected dogs to be entered for shows.
In the longer term, measures implemented by the Kennel Club will include analysis of all submitted data to create a research database that will provide an evidence-base to influence the future of dog welfare.
When asked about operations carried out on Kennel Club registered dogs, the majority of vets said that they do submit data on conformation altering surgeries (60%) and caesareans (65%) however 15% of survey respondents revealed that they never submit data. Those vets who do not always report gave ‘time’ as the main reason for not doing so.
BVA is working with its members to raise awareness of the Kennel Club’s new online system, which takes a few minutes to complete, to encourage a data drive that could reduce avoidable hereditary problems, prevent further lifelong discomfort and suffering, and improve health and welfare for dogs.
BVA President Sean Wensley said: "Vets are seeing concerning trends in dog health and welfare, especially with the current public want for designer dogs and brachycephalic breeds, so the need for a record of conformation altering surgeries and caesareans carried out in daily practice has never been more important. Owners can submit data on their dogs’ operations yet data from veterinary practices is vital for the Kennel Club’s evidence base as it offers additional validity that many owners are not able to provide, ensuring robust and informative data for now and the future."
Other reasons vets gave for not always submitting data on conformation altering surgeries and caesareans, included:
BVA is urging vets and practice teams to recognise the importance of submitting this data and to work with their clients to ensure delivery of the best welfare outcomes for dogs. To support its members, BVA has compiled FAQs on conformation altering surgery and will be taking further questions to the Kennel Club Dog Health Group. To assist with the process of data submission in daily practice, BVA has developed a poster that can be downloaded at www.bva.co.uk/dog-breeding.
The session will be conducted in the style of the BBC Radio 4 Moral Maze discussion programme, with panelists and witnesses arguing for and against the viewpoint corporatisation is inevitable and will benefit vets and their clients.
Moderated by Madeleine Campbell, Keith Chandler and Karl Holliman will argue for corporatisation and Andrew Harrison and Tim Greet will be against. They will call upon a series of 'witnesses' for detailed questioning before the topic is more broadly debated.
CVS, the UK’s biggest veterinary group now owns more than 410 veterinary practices, of which over 30 are specifically equine or mixed practices.
The latest equine acquisitions include Bell Equine, a one-site Equine Referral Hospital in Kent, in January 2017 and Severn Edge Veterinary Group, a mixed practice with 12 sites in Shropshire, including a six-vet dedicated equine practice, in April 2017.
One line of argument says that the commercial and business advantages of a corporate, together with their scale and diversity, can give veterinary surgeons greater potential for a more flexible career path and advancement within the industry, and a more sustainable working career in equine practice.
On the flip side, there's the removal of any opportunity to buy into ownership, reduced decision-making ability because of adherence to corporate procedures, extra paperwork, longer approval processes and an increased emphasis on the bottom line.
David Mountford, Chief Executive of BEVA said: "The auditorium is usually full to bursting for our Moral Maze sessions because they bring a broader and more engaging dimension to important topics. The statement Corporatisation of equine practices is inevitable and will benefit vets and their clients is bound to generate some stimulating and possibly heated debate."
This year's BEVA Congress will be held at Liverpool Arena Convention Centre, and anyone who registers before 3rd August will receive significantly reduced booking fees.
For more information, visit: www.beva.org.uk.
Extensively updated, the new edition reflects the increasing sophistication of reptile medicine and surgery and acknowledges the expanding range of reptile species kept as companion animals.
Part one covers the husbandry aspects of reptile care, including captive maintenance and nutrition, plus a new chapter dedicated to anatomy and physiology.
Part two contains the details necessary to carry out successful clinical examination, anaesthesia, surgery (including endoscopy), treatment (including emergency and critical care), non-invasive imaging, laboratory testing and post-mortem examinations, as well as humane euthanasia.
Part three addresses disease by organ system, covering parasitology and infectious disease.
New to this third edition are also chapters on marine turtle rehabilitation and crocodilians, as well as updates on the handling of venomous reptiles.
Simon Girling said: "This third edition of the BSAVA Manual of Reptiles is another milestone in the commitment of the BSAVA to exotic species medicine. Reptile medicine and surgery is now being accepted as a mainstream discipline within the veterinary world, reflected in the growing number of textbooks and the appearance of postgraduate qualifications."
BSAVA says the new manual will benefit both the general practitioner seeing a small number of reptiles or a more specialist practitioner dealing with these species on a daily basis.
Together, these two cancers account for almost a third of all canine cancers.
Dr. Heather Wilson-Robles, an Associate Professor at Texas A&M University and Chief Medical Officer of Volition Veterinary Diagnostics said: "The proof of concept results in these two very prevalent canine cancers give us confidence to move forward with other Nu.Q Vet assays in our pipeline, and with the larger range of cohorts and trials we have collected and planned.
"Clearly, we still have work to do as this single assay did not detect one of the other top five canine cancers, canine osteosarcoma, which was the third cancer tested in this study. However, I am delighted to see such positive results in these two significant cancers and look forward to reporting further data over the coming quarters with additional Nu.Q Vet assays, this time tested on an automated platform.”
Dr. Terry Kelly, Chief Scientific Officer of Volition America said: “It is exciting to see such strong results from our first Nu.Q Vet study conducted at Texas A&M University Veterinary Hospital. It is also interesting to note the similar patterns of detection seen in both canine and human samples confirming that the Nu.Q platform does appear to be useful in more than just human diagnostics.
"As with human diagnostics, there are currently no accurate, simple, affordable cancer screening tests available in veterinary medicine and yet 25% of dogs will develop cancer at some stage of their life. I look forward to completing the planned trials and to launch our first Nu.Q Vet product in the U.S. that we expect to occur in 2020."
This, say the authors, could lead to shorter hospitalisation time and less stress for donor cats.
For the study, researchers at the Royal Veterinary College measured the systolic blood pressure of 100 client-owned cats which had been randomly assigned to receive IVFT or no fluid after blood donation.
Owners were also contacted following donation to record any changes in their cat.
The results showed no significant difference in blood pressure between cats that received post-donation IVFT and those that didn't.
The main reported changes were minor bruising at the venepuncture site and mild lethargy, with no significant difference between the IVFT and no-IVFT groups.
These findings suggest that IVFT post-blood donation may not be necessary, as haemodynamic stability appears to be maintained despite the loss of blood.
Dr Guedra Allais, lead author of the study, said: "Our study showed no significant difference in blood pressure at different time points in feline donors that received intravenous fluid compared to others that didn’t receive any fluid.
"Other perfusion parameters such as capillary refill time, heart rate and pulse quality were not evaluated, and we recommend considering intravenous fluid in any feline donors if any major changes are detected on post donation physical examination.”